🇺🇸 FDA
Patent

US 8703200

Inhibition of neovascularization by cerium oxide nanoparticles

granted A61KA61K33/244A61K9/14

Quick answer

US patent 8703200 (Inhibition of neovascularization by cerium oxide nanoparticles) held by The Board of Regents of the University of Oklahoma expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K33/244, A61K9/14, A61P, A61P1/00